Literature DB >> 25004423

Angiotensin-converting enzyme genetic polymorphism.

Somsri Wiwanitkit, Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25004423      PMCID： PMC4079026          DOI： 10.5935/abc.20140077

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  7 in total

1.  Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure.

Authors:  B Andersson; I Blange; C Sylvén
Journal:  Eur J Heart Fail       Date:  1999-12       Impact factor: 15.534

2.  Association of angiotensin-converting enzyme I/D polymorphism with heart failure: a meta-analysis.

Authors:  Yuanyuan Bai; Liang Wang; Shengshou Hu; Yingjie Wei
Journal:  Mol Cell Biochem       Date:  2011-10-21       Impact factor: 3.396

3.  Association of echocardiographic left ventricular structure with the ACE D/I polymorphism: a meta-analysis.

Authors:  Tatiana Kuznetsova; Lutgarde Thijs; Tom Richart; Katarzyna Stolarz-Skrzypek; Robert Fagard; Paolo Manunta; Giuseppe Bianchi; Jan A Staessen
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2011-01-27       Impact factor: 1.636

4.  Association of left ventricular systolic performance and cavity size with angiotensin-converting enzyme genotype in idiopathic dilated cardiomyopathy.

Authors:  G P Candy; D Skudicky; U K Mueller; A J Woodiwiss; K Sliwa; F Luker; J Esser; P Sareli; G R Norton
Journal:  Am J Cardiol       Date:  1999-03-01       Impact factor: 2.778

5.  Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy.

Authors:  M V Raynolds; M R Bristow; E W Bush; W T Abraham; B D Lowes; L S Zisman; C S Taft; M B Perryman
Journal:  Lancet       Date:  1993-10-30       Impact factor: 79.321

6.  Angiotensin-converting enzyme gene polymorphism: I and D alleles from some different countries.

Authors:  Viroj Wiwanitkit
Journal:  Clin Appl Thromb Hemost       Date:  2004-04       Impact factor: 2.389

Review 7.  Expanding role of pharmacogenomics in the management of cardiovascular disorders.

Authors:  Vincent Lai Ming Yip; Munir Pirmohamed
Journal:  Am J Cardiovasc Drugs       Date:  2013-06       Impact factor: 3.571
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.